Aceto Corporation  

(Public, NASDAQ:ACET)   Watch this stock  
Find more results for ACET
25.71
+0.32 (1.26%)
Jul 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 25.15 - 25.95
52 week 19.20 - 32.20
Open 25.30
Vol / Avg. 182,376.00/169,797.00
Mkt cap 768.20M
P/E 18.20
Div/yield 0.06/0.93
EPS 1.41
Shares 29.59M
Beta 1.40
Inst. own 92%
Sep 8, 2016
Q4 2016 Aceto Corp Earnings Release (Estimated) Add to calendar
Jun 8, 2016
Aceto Corp at Jefferies Healthcare Conference
Jun 1, 2016
Aceto Corp at Craig-Hallum Institutional Investor Conference
May 6, 2016
Q3 2016 Aceto Corp Earnings Call - Webcast
May 5, 2016
Q3 2016 Aceto Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 6.60% 6.12%
Operating margin 10.43% 10.30%
EBITD margin - 14.26%
Return on average assets 7.82% 6.99%
Return on average equity 14.30% 13.73%
Employees 270 -
CDP Score - -

Address

4 Tri Harbor Ct
PORT WASHINGTON, NY 11050-4661
United States - Map
+1-516-6276000 (Phone)
+1-516-6276093 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Aceto Corporation (Aceto) is engaged in marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The Company's business is organized along product lines into three segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals. The Human Health segment includes finished dosage form generic drugs and nutraceutical products. The Pharmaceutical Ingredients segment has two product groups: Active Pharmaceutical Ingredients (APIs) and Pharmaceutical Intermediates. The Performance Chemicals segment includes specialty chemicals and agricultural protection products. The Company has operations in China, Germany, France, the Netherlands, Singapore, India, Hong Kong, Philippines, the United Kingdom and the United States.

Officers and directors

Albert L. Eilender Chairman of the Board
Age: 72
Bio & Compensation  - Reuters
Salvatore J. Guccione President, Chief Executive Officer, Director
Age: 53
Bio & Compensation  - Reuters
Douglas A Roth Chief Financial Officer, Senior Vice President
Age: 58
Bio & Compensation  - Reuters
Satish Srinivasan President and Chief Operating Officer of Rising Pharmaceuticals
Age: 46
Bio & Compensation  - Reuters
Steven Rogers Senior Vice President, General Counsel, Corporate Secretary
Age: 54
Bio & Compensation  - Reuters
Charles J. Alaimo Senior Vice President - Human Resources
Age: 49
Bio & Compensation  - Reuters
Raymond Bartone Senior Vice President - Nutritionals
Age: 53
Bio & Compensation  - Reuters
Frank V. DeBenedittis Senior Vice President - Corporate Business Development
Age: 61
Bio & Compensation  - Reuters
Terry Kippley Senior Vice President - Agricultural Protection Products
Age: 51
Bio & Compensation  - Reuters
Carlos Restrepo Senior Vice President - Performance Chemicals
Age: 53
Bio & Compensation  - Reuters